AC Immune SA annual stock-based compensation
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AC Immune SA Stock-Based Compensation Growth & History (ACIU)
AC Immune SA's stock-based compensation was CHF4.4M for fiscal 2025.
View full AC Immune SA company overviewAC Immune SA annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF4.4M | −CHF1.1M | −20.07% |
| 2024 | 2024-12-31 | CHF5.5M | CHF1.1M | +25.00% |
| 2023 | 2023-12-31 | CHF4.4M | CHF1.1M | +33.33% |
| 2022 | 2022-12-31 | CHF3.3M | −CHF800,000 | −19.51% |
| 2021 | 2021-12-31 | CHF4.1M | CHF0 | 0.00% |
| 2020 | 2020-12-31 | CHF4.1M | CHF1.3M | +46.43% |
| 2019 | 2019-12-31 | CHF2.8M | CHF282,000 | +11.20% |
| 2018 | 2018-12-31 | CHF2.5M | CHF939,000 | +59.47% |
| 2017 | 2017-12-31 | CHF1.6M | CHF262,000 | +19.89% |
| 2016 | 2016-12-31 | CHF1.3M | CHF777,000 | +143.89% |
| 2015 | 2015-12-31 | CHF540,000 | — | — |
AC Immune SA quarterly stock-based compensation
Q3.22
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | CHF904,000 | −CHF63,000 | −6.51% |
| Q3 2025 | 2025-09-30 | CHF813,000 | — | — |
| Q2 2025 | 2025-06-30 | CHF1.1M | −CHF300,000 | −21.43% |
| Q1 2025 | 2025-03-31 | CHF1.6M | — | — |
| Q4 2024 | 2024-12-31 | CHF967,000 | — | — |
| Q2 2024 | 2024-06-30 | CHF1.4M | — | — |
| Q3 2022 | 2022-09-30 | CHF555,000 | — | — |
AC Immune SA stock-based compensation trends
Over the last five fiscal years, AC Immune SA's stock-based compensation increased from CHF4.1M to CHF4.4M, a change of CHF296,000. The latest reported quarter, Q4 2025, shows CHF904,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA source filings ↗